TY  - RPRT
TI  - Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination With Nivolumab
AU  - Thudium, K.
AU  - Selby, M.
AU  - Zorn, J. A.
AU  - Rak, G.
AU  - Wang, X.-T.
AU  - Bunch, R. T.
AU  - Hogan, J. M.
AU  - Strop, P.
AU  - Korman, A. J.
PY  - 2022
DO  - 10.1101/2022.01.24.477551
UR  - https://www.biorxiv.org/content/10.1101/2022.01.24.477551v1
ID  - 10.1101/2022.01.24.477551
ER  -